Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Quest Diagnostics Inc.

DGX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of DGX by members of U.S. Congress

Politician Type Traded
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 30, 2026
Alan Armstrong Senate / R Purchase $1,001 - $15,000 Mar 27, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Feb 17, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 29, 2026
Julie Johnson House / D Sale $1,001 - $15,000 Nov 03, 2025
Julie Johnson House / D Sale $1,001 - $15,000 Oct 30, 2025
Julie Johnson House / D Purchase $1,001 - $15,000 Oct 30, 2025
Julia Letlow House / R Sale $1,001 - $15,000 Jul 24, 2025
Julia Letlow House / R Purchase $1,001 - $15,000 Apr 28, 2025
Carol D. Miller House / R Sale $1,001 - $15,000 Mar 10, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 17, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 15, 2024
Ro Khanna House / D Purchase $1,001 - $15,000 Nov 12, 2024
Earl Blumenauer House / D Sale $1,001 - $15,000 Apr 04, 2024
Ro Khanna House / D Sale None Mar 05, 2024
Ro Khanna House / D Exchange None Mar 05, 2024
Tommy Tuberville Senate / R Sale (Partial) $15,001 - $50,000 Jan 03, 2024
Thomas R. Carper Senate / D Sale (Partial) $1,001 - $15,000 Dec 11, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 05, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Dec 04, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 31, 2023
Ro Khanna House / D Sale $1,001 - $15,000 Sep 06, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Jun 29, 2023
Carol D. Miller House / R Purchase $1,001 - $15,000 Nov 14, 2022
Kathy E. Manning House / D Sale $1,001 - $15,000 Aug 03, 2022
Kathy E. Manning House / D Purchase $1,001 - $15,000 Jul 20, 2022
Michael T. McCaul House / R Sale $50,001 - $100,000 Mar 31, 2022
Michael T. McCaul House / R Sale $100,001 - $250,000 Mar 31, 2022
Earl Blumenauer House / D Sale $1,001 - $15,000 Mar 14, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Earl Blumenauer House / D Purchase $1,001 - $15,000 Feb 24, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 Jan 28, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 Jan 28, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 Jan 21, 2022
Ro Khanna House / D Sale $1,001 - $15,000 Jan 20, 2022
Michael T. McCaul House / R Sale $15,001 - $50,000 Jan 07, 2022
Michael T. McCaul House / R Sale $15,001 - $50,000 Jan 07, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2021
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2021
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Michael T. McCaul House / R Sale $15,001 - $50,000 Nov 04, 2021
Michael T. McCaul House / R Sale $50,001 - $100,000 Nov 04, 2021
Carol D. Miller House / R Purchase $15,001 - $50,000 Jul 28, 2021
Sara Jacobs House / D Sale $50,001 - $100,000 Apr 09, 2021
Tommy Tuberville Senate / R Purchase $1,001 - $15,000 Mar 29, 2021
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2020
Michael T. McCaul House / R Sale $1,001 - $15,000 Dec 14, 2020
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Michael T. McCaul House / R Sale $15,001 - $50,000 Jun 03, 2020
Michael T. McCaul House / R Sale $15,001 - $50,000 Jun 03, 2020
DGX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
DGX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
DGX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in DGX holdings by institutional investors

Quarterly net insider trading by DGX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $470,000 Jul 20, 2026 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $690,000 Apr 20, 2026 Issue: Health Issues Budget/Appropriations Medicare/Medicaid
  • $310,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $330,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $330,000 Jan 20, 2026 Issue: Health Issues Medicare/Medicaid Budget/Appropriations
  • $350,000 Jan 20, 2026 Issue: Budget/Appropriations Health Issues Medicare/Medicaid
  • $390,000 Jan 21, 2025 Issue: Health Issues Medicare/Medicaid
  • $430,000 Oct 21, 2024 Issue: Medicare/Medicaid Health Issues
  • $410,000 Oct 21, 2024 Issue: Medicare/Medicaid Health Issues
  • $520,000 Jul 22, 2024 Issue: Medicare/Medicaid Health Issues
  • $530,000 Jan 22, 2024 Issue: Medicare/Medicaid Health Issues
  • $530,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $520,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $320,000 Jan 20, 2023 Issue: Medicare/Medicaid Health Issues
  • $320,000 Oct 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $250,000 Jul 20, 2022 Issue: Medicare/Medicaid Health Issues
  • $190,000 Apr 19, 2022 Issue: Medicare/Medicaid Health Issues
  • $950,000 Jan 20, 2022 Issue: Health Issues Medicare/Medicaid
  • $320,000 Oct 20, 2021 Issue: Medicare/Medicaid Health Issues
  • $340,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $230,000 Apr 20, 2021 Issue: Health Issues Medicare/Medicaid
  • $220,000 Jan 20, 2021 Issue: Medicare/Medicaid Health Issues Homeland Security
  • $220,000 Oct 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $230,000 Jul 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $210,000 Apr 20, 2020 Issue: Medicare/Medicaid Health Issues
  • $170,000 Jan 20, 2020 Issue: None
  • $210,000 Oct 21, 2019 Issue: None
  • $240,000 Jul 19, 2019 Issue: Health Issues Medicare/Medicaid
  • $270,000 Apr 22, 2019 Issue: Medicare/Medicaid Health Issues
  • $520,000 Jan 21, 2019 Issue: Health Issues Medicare/Medicaid
  • $780,000 Oct 20, 2018 Issue: Health Issues Medicare/Medicaid
  • $280,000 Jul 20, 2018 Issue: Health Issues Medicare/Medicaid
  • $270,000 Apr 20, 2018 Issue: None
  • $280,000 Jan 19, 2018 Issue: None
  • $300,000 Oct 20, 2017 Issue: None
  • $280,000 Jul 20, 2017 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $240,000 Apr 20, 2017 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
  • $260,000 Jan 20, 2017 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
  • $270,000 Oct 20, 2016 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
  • $290,000 Jul 19, 2016 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $190,000 Apr 20, 2016 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $220,000 Jan 20, 2016 Issue: Medicare/Medicaid Defense Health Issues Medical/Disease Research/Clinical Labs
  • $200,000 Oct 20, 2015 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues Defense
  • $200,000 Jul 20, 2015 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Defense Health Issues
  • $150,000 Apr 20, 2015 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues Defense
  • $130,000 Jan 19, 2015 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Defense Health Issues
  • $150,000 Oct 20, 2014 Issue: Medicare/Medicaid Defense Medical/Disease Research/Clinical Labs Health Issues
  • $160,000 Jul 21, 2014 Issue: Medicare/Medicaid Defense Health Issues
  • $160,000 Apr 18, 2014 Issue: Medicare/Medicaid Health Issues
  • $130,000 Jan 21, 2014 Issue: Medicare/Medicaid Health Issues
  • $150,000 Oct 21, 2013 Issue: Medicare/Medicaid Health Issues
  • $200,000 Jul 19, 2013 Issue: Medicare/Medicaid Health Issues
  • $190,000 Apr 19, 2013 Issue: Medicare/Medicaid Health Issues
  • $120,000 Jan 21, 2013 Issue: Medicare/Medicaid Health Issues
  • $180,000 Oct 19, 2012 Issue: Medicare/Medicaid Health Issues
  • $170,000 Jul 19, 2012 Issue: Medicare/Medicaid Health Issues
  • $190,000 Apr 18, 2012 Issue: Medicare/Medicaid Health Issues
  • $190,000 Jan 19, 2012 Issue: Medicare/Medicaid Health Issues
  • $210,000 Oct 19, 2011 Issue: Medicare/Medicaid Health Issues
  • $270,000 Oct 19, 2011 Issue: Medicare/Medicaid Health Issues
  • $200,000 Jul 18, 2011 Issue: Health Issues
  • $220,000 Jan 18, 2011 Issue: Health Issues
  • $240,000 Oct 20, 2010 Issue: Health Issues
  • $220,000 Jul 18, 2010 Issue: Health Issues
  • $190,000 Apr 17, 2010 Issue: Health Issues
  • $190,000 Jan 19, 2010 Issue: Health Issues
  • $190,000 Oct 16, 2009 Issue: Health Issues
  • $160,000 Jul 16, 2009 Issue: None
  • $160,000 Apr 20, 2009 Issue: None
  • $120,000 Jan 15, 2009 Issue: None
  • $130,000 Oct 14, 2008 Issue: None
  • $160,000 Jul 17, 2008 Issue: Medicare/Medicaid Health Issues
  • $210,000 Jul 17, 2008 Issue: Health Issues Medicare/Medicaid
  • $75,000 Feb 14, 2008 Issue: Health Issues
  • $75,000 Aug 14, 2007 Issue: Health Issues
  • $75,000 Jan 30, 2007 Issue: Health Issues
  • $60,000 Aug 10, 2006 Issue: Health Issues
  • $75,000 Jun 21, 2006 Issue: Health Issues Medicare/Medicaid
  • $45,000 Aug 24, 2005 Issue: Medicare/Medicaid
  • $50,018 Feb 23, 2005 Issue: Medicare/Medicaid
  • $75,000 Aug 24, 2004 Issue: Health Issues Medicare/Medicaid
  • $60,000 Feb 17, 2004 Issue: Medicare/Medicaid
  • $60,000 Aug 13, 2003 Issue: Medicare/Medicaid
  • $60,000 Feb 20, 2003 Issue: Medicare/Medicaid
  • $60,000 Aug 29, 2002 Issue: Medicare/Medicaid
  • $50,000 Mar 15, 2002 Issue: Medicare/Medicaid
  • $60,000 Jul 03, 2001 Issue: Medicare/Medicaid
  • $40,000 Feb 14, 2001 Issue: Medicare/Medicaid
  • $40,000 Aug 09, 2000 Issue: Medicare/Medicaid
  • $40,000 Feb 14, 2000 Issue: Medicare/Medicaid Health Issues
  • $40,000 Aug 16, 1999 Issue: Health Issues Medicare/Medicaid

Former government officials who have lobbied for DGX

31 former government officials from 16 congressional offices at 7 lobbying firms have lobbied for DGX, most recently Jul 21, 2026.

  • Paul Brathwaite Congress Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; Special Assistant, U.S. Secretary of Labor, Department of Labor. Formerly Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Andy Levin
    Ven Neralla House New Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff, U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep. Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio; Senior Advisor, USDA; OPP; and MCC. Formerly with Andy Levin · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Amy Klobuchar
    Kaade Wallace Senate New Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum Formerly with Amy Klobuchar · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Zoe Lofgren
    Stacey Leavandosky House New Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation Formerly with Zoe Lofgren · FEDERAL STREET STRATEGIES, LLC · Jul 21, 2026
  • Johnny Isakson
    Annabell Stokes Senate New Counsel, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2020) Law Clerk, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2018) Formerly with Johnny Isakson · RED+BLUE STRATEGIES · Jul 17, 2026
  • Jennifer Young Congress Asst. Sec. for Leg.- HHS; Dep. Asst. Sec for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff. Sen. Cmte. on Finance Formerly Cmte. on Finance · TARPLIN, DOWNS & YOUNG, LLC · Jul 16, 2026
  • Steny H. Hoyer
    Elizabeth Murray House Senior Policy Advisor, Democratic Whip Steny Hoyer; Leg. Asst., Rep. Mike Thompson, Rep. Bob Matsui, and Sen. Bob Graham Formerly with Steny H. Hoyer · TARPLIN, DOWNS & YOUNG, LLC · Jul 16, 2026
  • Jim DeMint
    Charlotte Ivancic Senate Leg. Counsel, Sen. Jim DeMint; Health Counsel, Maj. Leader Bill Frist; Counsel and Budget Analyst, House Budget Cmte.; Asst. to the Speaker for Policy, Speaker John Boehner Formerly with Jim DeMint · TARPLIN, DOWNS & YOUNG, LLC · Jul 16, 2026
See all 31 on the Revolving Door dashboard

DGX Estimated quarterly lobbying spending

DGX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
DGX Income Statement
DGX Balance Sheet
DGX Cash Flow
U.S. Patents

New DGX patent grants

  • Patent Title: Method for determining penetration opportunity of a drug into a physician market Jan. 21, 2014
  • Patent Title: Fluorescence energy transfer by competitive hybridization Sep. 28, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to DGX from public contracts

DGX News

Recent insights relating to DGX

CNBC Recommendations

Recent picks made for DGX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in DGX

DGX Analyst Ratings

DGX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
DGX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $DGX stock a Buy, Sell, or Hold?

  • What is the price target for $DGX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

DGX Top Shareholders
Shareholder
Shares Held
DGX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $DGX stock?

  • Who owns the most shares of $DGX stock?

  • What funds own $DGX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

DGX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view DGX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About DGX

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.

  • Address Secaucus, NJ
  • Market Cap 26.1 billion
  • Employees 57,000
  • Industrial Classification Services-Medical Laboratories

Quest Diagnostics Inc. (DGX) Historical Stock Prices

Quest Diagnostics Inc. (DGX) closed at $236.59 on September 24, 2026. Over the past year its adjusted close ranged from $171.27 to $247.45. Daily prices go back to January 2, 2014, 3,201 trading days in all.

  • 1 month-3.24%
  • 3 months+15.19%
  • Year to date+38.11%
  • 1 year+28.85%
  • 3 years+101.86%
  • 5 years+70.32%
  • Max+478.56%
See every congressional and insider trade on the DGX price chart

Quiver Premium charts DGX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 24, 2026 234.08 237.29 233.55 236.59 236.59 926,898
Sep 23, 2026 235.12 238.62 231.92 233.00 233.00 1,129,646
Sep 22, 2026 228.59 237.28 227.24 234.76 234.76 2,719,288
Sep 21, 2026 247.13 248.84 243.93 244.88 244.88 907,605
Sep 18, 2026 246.52 247.62 244.89 246.45 246.45 1,925,637
Sep 17, 2026 248.28 248.69 246.26 247.45 247.45 989,497
Sep 16, 2026 245.47 248.57 244.85 247.08 247.08 948,753
Sep 15, 2026 238.39 248.65 237.21 247.08 247.08 1,373,615
Sep 14, 2026 237.49 239.78 234.67 237.89 237.89 974,850
Sep 11, 2026 233.20 235.12 229.33 235.02 235.02 997,025
Sep 10, 2026 236.32 236.47 228.57 231.14 231.14 1,090,546
Sep 9, 2026 233.58 236.24 232.43 235.46 235.46 791,149
Sep 8, 2026 233.61 237.56 231.52 235.50 235.50 728,935
Sep 4, 2026 235.38 238.91 235.38 237.14 237.14 798,704
Sep 3, 2026 242.00 242.00 236.35 239.40 239.40 1,043,291
Sep 2, 2026 238.03 242.84 236.27 240.80 240.80 1,144,114
Sep 1, 2026 242.72 243.72 235.62 236.22 236.22 813,392
Aug 31, 2026 241.99 242.63 239.40 240.30 240.30 1,358,258
Aug 28, 2026 245.17 245.28 242.27 242.76 242.76 639,937
Aug 27, 2026 242.83 247.19 242.44 244.61 244.61 839,989
Aug 26, 2026 244.11 246.00 243.49 245.00 245.00 811,024
Aug 25, 2026 243.93 245.78 241.79 244.51 244.51 709,151
Aug 24, 2026 243.97 246.00 242.46 243.87 243.87 837,736
Aug 21, 2026 240.33 244.70 239.43 244.39 244.39 1,263,229
Aug 20, 2026 239.86 245.68 237.53 241.30 241.30 1,139,473
Aug 19, 2026 238.10 242.39 237.38 241.76 241.76 924,012
Aug 18, 2026 238.01 239.38 236.07 236.25 236.25 693,609
Aug 17, 2026 233.94 237.17 233.00 235.52 235.52 614,271
Aug 14, 2026 235.82 237.69 233.69 234.40 234.40 541,802
Aug 13, 2026 239.10 240.00 235.65 236.04 236.04 549,033
Aug 12, 2026 234.46 238.51 232.28 237.77 237.77 686,871
Aug 11, 2026 236.35 239.92 235.51 237.50 237.50 847,026
Aug 10, 2026 236.53 239.33 235.85 237.63 237.63 856,190
Aug 7, 2026 236.34 239.38 236.34 238.35 238.35 574,521
Aug 6, 2026 237.66 238.88 235.31 238.50 238.50 642,223
Aug 5, 2026 234.22 236.66 232.56 235.84 235.84 674,201
Aug 4, 2026 231.95 234.54 229.75 233.72 233.72 903,998
Aug 3, 2026 232.84 233.44 230.54 231.95 231.95 839,251
Jul 31, 2026 234.00 235.28 232.00 233.01 233.01 872,677
Jul 30, 2026 230.91 235.61 229.01 234.30 234.30 947,709
Jul 29, 2026 235.11 237.84 233.00 235.22 235.22 964,462
Jul 28, 2026 235.18 240.13 233.98 235.94 235.94 1,611,964
Jul 27, 2026 225.95 231.95 224.97 231.84 231.84 1,143,249
Jul 24, 2026 228.00 233.21 223.42 227.86 227.86 1,542,112
Jul 23, 2026 228.09 237.78 220.00 227.90 227.90 3,758,554
Jul 22, 2026 207.13 212.30 205.41 209.83 209.83 1,834,085
Jul 21, 2026 206.16 208.01 204.10 206.84 206.84 691,873
Jul 20, 2026 208.61 211.00 205.61 207.66 207.66 822,912
Jul 17, 2026 210.95 214.40 209.41 210.68 210.68 955,495
Jul 16, 2026 201.00 209.56 201.00 209.41 209.41 991,687
Jul 15, 2026 204.68 206.41 201.12 201.77 201.77 1,193,176
Jul 14, 2026 202.80 208.52 201.13 206.00 206.00 865,890
Jul 13, 2026 207.48 210.76 207.01 207.35 207.35 568,927
Jul 10, 2026 208.25 209.86 207.03 207.44 207.44 614,849
Jul 9, 2026 210.20 210.20 206.34 208.05 208.05 621,208
Jul 8, 2026$0.86 dividend 210.74 210.74 207.23 208.21 208.21 773,651
Jul 7, 2026 216.89 219.20 212.12 212.38 211.51 981,082
Jul 6, 2026 215.64 216.52 212.57 213.45 212.57 745,939
Jul 2, 2026 217.07 217.41 214.94 215.72 214.83 869,667
Jul 1, 2026 213.67 216.87 211.40 216.02 215.13 1,004,081
Jun 30, 2026 212.89 214.21 210.67 211.95 211.08 847,825
Jun 29, 2026 207.97 212.76 206.97 212.64 211.76 786,336
Jun 26, 2026 207.97 209.89 206.55 209.88 209.02 1,349,745
Jun 25, 2026 203.14 207.85 203.14 206.24 205.39 632,360
Jun 24, 2026 198.41 205.76 198.41 203.11 202.28 1,135,807
Jun 23, 2026 195.78 197.79 194.15 197.18 196.37 987,971
Jun 22, 2026 194.13 195.16 192.90 193.58 192.78 904,816
Jun 18, 2026 196.69 197.44 192.83 195.00 194.20 1,292,236
Jun 17, 2026 200.00 201.04 196.50 197.76 196.95 754,169
Jun 16, 2026 203.03 204.70 199.66 201.04 200.21 1,020,330
Jun 15, 2026 202.25 203.20 200.37 202.18 201.35 1,009,385
Jun 12, 2026 205.53 205.96 202.38 203.06 202.22 898,894
Jun 11, 2026 204.07 207.50 202.54 203.83 202.99 1,079,981
Jun 10, 2026 203.35 207.30 202.97 203.78 202.94 786,592
Jun 9, 2026 197.90 204.84 196.99 204.53 203.69 747,133
Jun 8, 2026 202.08 202.08 196.70 197.21 196.40 821,692
Jun 5, 2026 197.41 201.54 197.31 200.29 199.47 816,170
Jun 4, 2026 194.99 201.99 194.99 196.12 195.31 735,926
Jun 3, 2026 193.00 195.21 192.38 193.67 192.87 648,074
Jun 2, 2026 192.93 193.31 191.01 193.16 192.37 678,596
Jun 1, 2026 194.14 196.48 191.85 192.20 191.41 609,501
May 29, 2026 196.59 197.38 194.29 194.90 194.10 1,264,321
May 28, 2026 194.03 196.79 193.91 196.20 195.39 653,708
May 27, 2026 194.26 196.32 192.57 193.99 193.19 597,235
May 26, 2026 194.26 194.69 192.35 192.88 192.09 869,412
May 22, 2026 193.99 196.92 193.96 195.21 194.41 871,497
May 21, 2026 192.73 193.83 188.88 193.82 193.02 473,967
May 20, 2026 191.87 194.85 190.40 193.75 192.95 948,706
May 19, 2026 189.24 191.18 187.06 190.39 189.61 794,562
May 18, 2026 187.64 191.16 187.25 189.84 189.06 926,152
May 15, 2026 189.16 189.88 186.43 186.61 185.84 1,081,530
May 14, 2026 190.92 192.80 187.14 187.94 187.17 768,064
May 13, 2026 188.81 191.11 187.51 190.85 190.06 693,146
May 12, 2026 191.21 192.30 189.47 190.18 189.40 754,932
May 11, 2026 187.36 190.45 187.13 189.81 189.03 620,698
May 8, 2026 191.71 192.20 186.23 187.39 186.62 762,516
May 7, 2026 188.19 190.99 187.90 190.84 190.06 739,973
May 6, 2026 190.89 192.62 188.49 189.13 188.35 898,644
May 5, 2026 191.39 191.70 189.18 190.84 190.06 613,834
May 4, 2026 190.61 193.50 190.41 191.50 190.71 567,482
May 1, 2026 194.50 196.34 192.21 192.67 191.88 691,960
Apr 30, 2026 190.24 195.87 189.91 194.20 193.40 1,109,986
Apr 29, 2026 193.85 194.49 187.50 189.32 188.54 1,399,922
Apr 28, 2026 198.59 198.78 194.27 195.05 194.25 909,135
Apr 27, 2026 195.91 198.00 195.61 196.63 195.82 702,929
Apr 24, 2026 199.99 200.07 194.46 196.27 195.46 1,038,852
Apr 23, 2026 205.28 205.66 196.96 199.53 198.71 1,263,389
Apr 22, 2026 205.37 207.00 198.71 204.00 203.16 1,609,415
Apr 21, 2026 203.25 209.79 202.13 205.04 204.20 2,426,163
Apr 20, 2026 194.22 196.77 191.63 196.31 195.50 1,964,250
Apr 17, 2026 190.23 196.45 190.23 195.02 194.22 1,000,067
Apr 16, 2026 191.22 194.27 191.15 191.46 190.67 987,366
Apr 15, 2026 193.17 194.28 191.04 191.42 190.63 877,973
Apr 14, 2026 192.27 194.26 191.16 194.16 193.36 885,499
Apr 13, 2026 191.03 193.13 189.72 192.91 192.12 898,996
Apr 10, 2026 197.66 197.66 190.12 191.51 190.72 1,044,169
Apr 9, 2026 197.93 199.41 196.55 197.82 197.01 718,355
Apr 8, 2026 196.18 198.89 194.02 198.81 197.99 799,277
Apr 7, 2026 199.49 201.00 195.70 196.81 196.00 908,927
Apr 6, 2026$0.86 dividend 196.87 199.22 196.57 198.96 198.14 477,839
Apr 2, 2026 196.66 199.14 196.06 198.02 196.36 519,962
Apr 1, 2026 195.51 198.86 194.09 197.69 196.03 587,379
Mar 31, 2026 194.86 198.95 192.73 195.98 194.33 1,268,735
Mar 30, 2026 196.67 197.56 194.72 197.16 195.50 865,570
Mar 27, 2026 197.93 198.63 194.57 195.51 193.87 976,313
Mar 26, 2026 196.24 198.88 195.00 198.15 196.49 706,214
Mar 25, 2026 196.77 197.72 194.28 196.46 194.81 679,761
Mar 24, 2026 194.58 197.03 193.81 196.08 194.43 759,239
Mar 23, 2026 197.33 202.91 195.23 195.60 193.96 881,169
Mar 20, 2026 194.07 196.83 192.79 195.26 193.62 2,030,142
Mar 19, 2026 195.01 197.21 193.91 194.16 192.53 806,594
Mar 18, 2026 197.07 201.49 194.88 195.23 193.59 694,228
Mar 17, 2026 200.70 200.70 197.18 198.61 196.94 795,424
Mar 16, 2026 200.98 201.88 198.86 198.94 197.27 777,162
Mar 13, 2026 202.84 205.00 199.09 199.70 198.02 663,197
Mar 12, 2026 200.34 203.00 199.97 200.88 199.19 772,795
Mar 11, 2026 199.99 201.71 198.37 200.56 198.88 646,704
Mar 10, 2026 203.15 204.39 198.87 200.90 199.21 675,986
Mar 9, 2026 198.25 202.47 195.39 201.58 199.89 819,621
Mar 6, 2026 203.76 203.78 199.01 199.21 197.54 1,055,725
Mar 5, 2026 206.21 206.21 203.47 203.98 202.27 604,125
Mar 4, 2026 208.14 209.76 207.11 208.45 206.70 508,312
Mar 3, 2026 207.73 209.82 203.89 208.36 206.61 779,701
Mar 2, 2026 212.52 213.26 209.43 210.25 208.48 922,368
Feb 27, 2026 211.09 213.50 208.97 211.91 210.13 1,058,749
Feb 26, 2026 208.67 211.56 208.09 211.10 209.33 783,746
Feb 25, 2026 209.52 210.69 206.13 207.80 206.06 798,327
Feb 24, 2026 207.81 209.90 206.35 209.54 207.78 882,102
Feb 23, 2026 201.99 207.72 201.99 207.43 205.69 783,079
Feb 20, 2026 204.36 204.41 200.94 202.41 200.71 642,091
Feb 19, 2026 204.83 205.09 202.00 202.44 200.74 815,555
Feb 18, 2026 205.27 206.75 203.17 204.39 202.67 871,747
Feb 17, 2026 207.99 208.93 202.82 205.49 203.76 971,250
Feb 13, 2026 207.48 209.39 204.58 206.87 205.13 1,354,595
Feb 12, 2026 211.80 213.20 206.81 206.86 205.12 1,671,555
Feb 11, 2026 207.04 210.38 201.99 209.32 207.56 1,431,227
Feb 10, 2026 194.72 207.05 191.90 205.35 203.62 2,307,873
Feb 9, 2026 190.00 191.78 187.58 191.25 189.64 1,925,583
Feb 6, 2026 193.20 193.60 189.94 190.71 189.11 1,099,523
Feb 5, 2026 190.00 193.46 188.65 192.30 190.69 1,635,791
Feb 4, 2026 185.34 189.80 185.13 189.23 187.64 1,337,516
Feb 3, 2026 184.78 189.13 184.69 185.17 183.62 807,907
Feb 2, 2026 186.01 186.93 182.36 185.00 183.45 1,003,761
Jan 30, 2026 183.81 187.19 183.81 187.03 185.46 1,164,074
Jan 29, 2026 182.17 183.97 181.68 182.35 180.82 635,677
Jan 28, 2026 183.02 183.58 181.62 182.74 181.21 838,875
Jan 27, 2026 181.51 184.39 181.47 184.24 182.69 667,916
Jan 26, 2026 182.14 183.79 181.37 182.53 181.00 681,866
Jan 23, 2026 181.94 182.44 179.73 181.02 179.50 848,894
Jan 22, 2026 185.11 185.47 182.01 182.16 180.63 1,754,222
Jan 21, 2026 189.02 189.75 184.43 184.65 183.10 1,140,357
Jan 20, 2026 187.69 191.07 186.83 188.95 187.36 1,482,016
Jan 16, 2026 189.40 190.96 188.75 189.49 187.90 1,132,571
Jan 15, 2026 187.15 190.99 186.43 190.26 188.66 1,245,699
Jan 14, 2026 180.50 187.09 179.83 186.77 185.20 1,498,946
Jan 13, 2026$0.8 dividend 176.86 180.42 175.47 179.96 178.45 1,069,588
Jan 12, 2026 175.81 176.06 173.51 175.94 173.69 695,248
Jan 9, 2026 177.52 178.29 174.43 174.44 172.21 942,357
Jan 8, 2026 178.19 180.66 176.70 177.74 175.47 870,097
Jan 7, 2026 181.15 181.23 177.70 178.14 175.86 767,267
Jan 6, 2026 173.38 181.22 173.38 180.46 178.15 1,165,444
Jan 5, 2026 173.46 174.49 171.18 173.49 171.27 748,829
Jan 2, 2026 173.31 173.81 172.03 173.79 171.57 683,170
Dec 31, 2025 175.49 175.72 173.39 173.53 171.31 645,305
Dec 30, 2025 175.30 176.37 175.03 175.49 173.25 732,816
Dec 29, 2025 175.72 176.34 174.63 175.52 173.28 632,023
Dec 26, 2025 176.47 176.73 175.65 175.94 173.69 402,681
Dec 24, 2025 175.74 176.25 175.13 175.92 173.67 296,509
Dec 23, 2025 176.55 176.55 174.48 175.08 172.84 652,768
Dec 22, 2025 176.00 177.24 175.62 176.34 174.09 704,270
Dec 19, 2025 175.80 176.83 174.59 176.06 173.81 1,580,889
Dec 18, 2025 179.19 179.80 176.03 176.15 173.90 973,822
Dec 17, 2025 178.33 179.23 177.02 179.10 176.81 1,652,324
Dec 16, 2025 184.84 184.84 178.52 178.66 176.38 1,338,939
Dec 15, 2025 183.25 184.81 182.96 184.11 181.76 951,930
Dec 12, 2025 182.16 183.01 181.23 182.56 180.22 1,138,995
Dec 11, 2025 179.64 182.06 179.51 181.57 179.25 685,602
Dec 10, 2025 180.00 180.99 178.95 179.51 177.21 1,071,131
Dec 9, 2025 181.71 182.77 178.61 179.62 177.32 846,482
Dec 8, 2025 182.29 183.50 181.23 181.82 179.50 980,691
Dec 5, 2025 183.20 184.19 182.08 182.51 180.18 738,192
Dec 4, 2025 182.31 185.12 182.25 184.18 181.82 1,044,861
Dec 3, 2025 183.27 184.16 182.21 182.61 180.28 1,057,340
Dec 2, 2025 183.80 184.88 182.21 182.55 180.22 1,177,547
Dec 1, 2025 188.50 189.38 183.66 183.77 181.42 1,175,803
Nov 28, 2025 190.12 190.25 188.94 189.18 186.76 379,697
Nov 26, 2025 191.44 192.25 189.22 189.69 187.26 869,621
Nov 25, 2025 191.76 193.34 190.72 192.35 189.89 1,207,322
Nov 24, 2025 192.75 192.75 189.74 190.58 188.14 2,285,266
Nov 21, 2025 188.11 193.76 187.80 191.25 188.80 1,769,771
Nov 20, 2025 187.14 188.76 186.25 187.61 185.21 1,104,444
Nov 19, 2025 185.34 187.68 184.18 185.96 183.58 874,623
Nov 18, 2025 187.35 188.16 184.35 185.32 182.95 1,368,410
Nov 17, 2025 187.01 189.25 185.09 186.19 183.81 1,086,531
Nov 14, 2025 186.89 188.89 186.12 186.95 184.56 923,858
Nov 13, 2025 185.60 190.47 184.50 187.58 185.18 1,411,985
Nov 12, 2025 188.36 189.07 186.81 186.85 184.46 1,076,555
Nov 11, 2025 184.98 191.31 184.84 188.85 186.44 1,293,710
Nov 10, 2025 178.20 184.59 175.76 184.31 181.95 1,592,564
Nov 7, 2025 177.14 180.59 176.09 179.50 177.21 1,020,675
Nov 6, 2025 177.99 178.98 175.67 176.51 174.25 830,158
Nov 5, 2025 177.81 179.38 176.85 178.26 175.98 784,855
Nov 4, 2025 179.35 180.04 176.27 178.03 175.75 1,059,509
Nov 3, 2025 175.78 179.15 174.36 178.84 176.55 1,106,898
Oct 31, 2025 174.33 176.81 174.33 175.95 173.70 966,249
Oct 30, 2025 175.24 178.88 174.91 175.75 173.50 1,427,075
Oct 29, 2025 178.30 178.76 174.70 174.78 172.54 1,014,840
Oct 28, 2025 179.80 180.63 177.17 178.28 176.00 1,434,053
Oct 27, 2025 181.37 182.16 179.74 180.26 177.96 900,956
Oct 24, 2025 183.99 184.73 181.94 182.18 179.85 867,086
Oct 23, 2025 181.96 183.38 179.53 183.23 180.89 1,230,913
Oct 22, 2025 184.88 186.46 180.84 181.17 178.85 1,583,501
Oct 21, 2025 195.08 197.55 179.86 184.64 182.28 2,889,878
Oct 20, 2025 190.69 191.87 189.50 190.41 187.97 1,491,058
Oct 17, 2025 187.61 190.08 187.05 189.51 187.09 983,924
Oct 16, 2025 187.50 188.71 186.28 186.82 184.43 1,056,574
Oct 15, 2025 185.56 188.11 185.19 187.35 184.95 1,071,939
Oct 14, 2025 182.82 185.70 182.77 185.39 183.02 718,536
Oct 13, 2025 182.71 184.24 181.82 182.78 180.44 809,300
Oct 10, 2025 182.30 184.33 181.42 184.07 181.72 737,071
Oct 9, 2025 181.05 182.79 180.98 181.44 179.12 538,698
Oct 8, 2025 181.52 181.62 178.54 180.89 178.58 745,336
Oct 7, 2025 179.77 184.48 178.76 181.89 179.56 1,110,648
Oct 6, 2025 178.00 179.62 177.39 178.43 176.15 843,975
Oct 3, 2025$0.8 dividend 179.94 180.68 178.25 179.33 177.04 1,395,240
Oct 2, 2025 180.83 182.00 177.79 180.96 177.85 1,029,737
Oct 1, 2025 190.68 190.98 181.81 182.07 178.94 1,782,108
Sep 30, 2025 188.88 191.49 188.88 190.58 187.31 780,511
Sep 29, 2025 188.99 189.48 187.76 188.84 185.60 528,005
Sep 26, 2025 186.29 189.23 185.17 188.99 185.75 551,836
Sep 25, 2025 186.71 187.26 183.62 185.39 182.21 657,780
Sep 24, 2025 186.49 187.92 185.98 186.82 183.61 748,102

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Quest Diagnostics Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at DGX, per a recent SEC DEF 14A filing. We estimate that the median employee at QUEST DIAGNOSTICS INC is paid $59,575.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation